New liver stent aims to tame deadly cirrhosis complications
NCT ID NCT06669806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special stent called LIVERTY TIPS, placed in the liver to create a new pathway for blood flow in people with cirrhosis and high blood pressure in the liver. The goal is to see if it can keep the new channel open and reduce problems like bleeding or fluid buildup. About 166 adults with cirrhosis and related complications will be followed for 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TIPS stent graft (a mesh tube placed in the liver to create a new blood flow channel)
What this could lead to
If successful, this stent could offer a safer, more effective way to manage serious complications of cirrhosis, reducing the need for repeat procedures.
What could go wrong
This is an early-stage, single-arm study with no comparison group, so results may not be definitive. Risks include stent blockage, infection, or worsening liver function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan Provincial People's Hospital
RECRUITINGChangsha, Hunan, 410005, China
Contact Phone: •••-•••-•••• Email: •••••@•••••